By this effort, we could map the activity of one group of small molecules to the inhibition of the lipogenic diacylglycerol acyltransferase 1 (DGAT1) enzyme, which is a known human obesity drug target. The gene discussed is DGAT1; the disease is obesity due to melanocortin 4 receptor deficiency.